Improving Ethical Care for Patients who are Incapacitated with No Evident Advance Directives or Surrogates (INEADS)
改善对没有明显预先指示或代理人的无行为能力患者的道德护理 (INEADS)
基本信息
- 批准号:10248503
- 负责人:
- 金额:$ 20.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-28 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdvance DirectivesAdvocateAmericanAreaBeliefBioethicsCaringCharacteristicsClinicalCommunitiesComplexDataDatabasesDecision MakingDevelopmentDiagnosisEducationElectronic Health RecordEthicsEvaluationEventFamilyFocus GroupsFriendsGeriatricsGoalsHealth PersonnelHealthcareHome Care ServicesHospital EthicsHospitalizationHospitalsHuman ResourcesIndependent LivingInstitutional PolicyIntervention StudiesInterviewKnowledgeLiteratureMeasuresMedicalMedical Care TeamNational Institute of Nursing ResearchNatural Language ProcessingPalliative CarePatient CarePatient PreferencesPatientsPilot ProjectsPoliciesPopulationPositioning AttributePrevalenceProceduresProcessProxyPublishingRecommendationResearchRiskSamplingSocietiesStandardizationStatutes and LawsStrategic PlanningTestingTimeLineUpdateVoiceWorkacute carebasecare preferenceclinical decision-makingcohortcourtdesignend of lifeend of life careexperiencefamily supporthigh riskimprovedpatient populationpreferencepreventprogramssocialstructured datasurrogate decision maker
项目摘要
Most Americans do not have advance directives or appointed surrogates to guide their medical care in
the event that they lose the capacity to make decisions for themselves. Healthcare teams are sometimes able
to identify “default” surrogates, i.e., family or friends who can provide information about the patient's values,
goals, preferences, and beliefs. However, a growing number of patients become decisionally incapacitated
without any advance directives, appointed surrogates, or default surrogates, which leaves them vulnerable to
receiving care that is unaligned with these tenets. Currently there is almost no data describing the prevalence
of patients who are Incapacitated with No Evident Advance Directives or Surrogates (INEADS) or how clinical
decisions are made for them. The proposed study will address this gap with two specific aims.
In Aim 1 we will determine (1a) what are the prevalence and characteristics of adults who are INEADS
or at risk of becoming INEADS, and (1b) how clinical decisions are currently made for patients who are
INEADS. For this aim we will retrospectively review electronic health records from an acute care database of
~40,000 hospitalizations and a home healthcare care database of ~89,000 community dwelling patients using
a combination of structured data, natural language processing, and content analysis to answer the following
questions: (i) What is the prevalence of patients who are currently INEADS and at risk of becoming INEADS in
acute care and homecare settings; (ii) Who are the hospital and community personnel and policies involved,
(iii) How do patient characteristics and diagnoses influence decisions, and (iv) What is the timeline for making
decisions and how expeditiously are decisions reached?
In Aim 2 we will qualitatively explore the phenomenon of INEADS from clinical and patient perspectives.
For this aim we will conduct: (1) focus groups with hospital- and community-based healthcare providers and
hospital ethics boards, and (2) interviews with community-dwelling patients at risk of becoming INEADS.
Sample questions to be explored include (i) What are the barriers and facilitators to formalizing and
standardizing the clinical decision-making process for INEADS patients, and (ii) What are the barriers and
facilitators to completing advance directives and designating surrogate decision makers among patients at risk
of becoming INEADS?
The long-term goal of this project is to provide vulnerable INEADS patients with ethical care that is
concordant with their goals and preferences. Knowledge gained from this pilot will inform (1) an intervention
study to increase advance directive completion and surrogate designation among patients at risk of becoming
INEADS, (2) the development, implementation, and evaluation of formalized decision-making processes for
INEADS patients, and (3) the design, delivery, and testing of clinician education on best practices for caring for
INEADS patients and patients at risk of becoming INEADS.
大多数美国人没有预先指示或指定的代理人来指导他们的医疗护理,
他们失去了为自己做决定的能力。医疗团队有时能够
为了识别“默认”代理,即,可以提供患者价值观信息的家人或朋友,
目标、偏好和信念。然而,越来越多的患者变得决策能力丧失,
没有任何预先指示,指定的代理人,或默认的代理人,这使得他们容易受到
接受与这些原则不一致的护理。目前,几乎没有数据描述
无明显预先指令或替代品(INEADS)或临床
决定是为他们做的。拟议的研究将通过两个具体目标解决这一差距。
在目标1中,我们将确定(1a)成人INEADS的患病率和特征
或有成为INEADS的风险,以及(1b)目前如何为
INEADS。为此,我们将回顾性地审查来自急性护理数据库的电子健康记录,
约40,000例住院病例和约89,000例社区居住患者的家庭医疗保健数据库,
结构化数据、自然语言处理和内容分析的组合可回答以下问题
问题:(i)目前为INEADS且有成为INEADS风险的患者的患病率
急性护理和家庭护理环境;(二)谁是医院和社区人员和政策涉及,
(iii)患者的特征和诊断如何影响决策,以及(iv)做出决策的时间轴是什么
决定,以及如何迅速作出决定?
在目标2中,我们将从临床和患者的角度定性探讨INEADS现象。
为此,我们将开展:(1)与医院和社区医疗服务提供者的焦点小组,
医院伦理委员会,和(2)与社区居民的病人在成为INEADS的风险访谈。
有待探讨的问题包括:(一)在正式确定和
标准化INEADS患者的临床决策过程,以及(ii)障碍和
协助完成预先指示并在风险患者中指定代理决策者
成为INEADS?
该项目的长期目标是为脆弱的INEADS患者提供道德关怀,
与他们的目标和偏好一致。从该试点中获得的知识将为(1)干预提供信息
研究,以增加提前指令完成和替代指定的患者中的风险成为
INEADS,(2)制定、实施和评估正式的决策过程,
INEADS患者,以及(3)设计,交付和测试临床医生教育的最佳做法,照顾
INEADS患者和有成为INEADS风险的患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bevin Cohen其他文献
Bevin Cohen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bevin Cohen', 18)}}的其他基金
Translational Research and Implementation Science for Nurses (TRAIN) Program 2.0
护士转化研究和实施科学 (TRAIN) 计划 2.0
- 批准号:
10680769 - 财政年份:2023
- 资助金额:
$ 20.72万 - 项目类别:
Improving Ethical Care for Patients who are Incapacitated with No Evident Advance Directives or Surrogates (INEADS)
改善对没有明显预先指示或代理人的无行为能力患者的道德护理 (INEADS)
- 批准号:
10038963 - 财政年份:2020
- 资助金额:
$ 20.72万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 20.72万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 20.72万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 20.72万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 20.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 20.72万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 20.72万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 20.72万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 20.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 20.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 20.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)